Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Signos
AddedFeb 17, 2024
UpdatedJun 18, 2026
Signos

Signos

Series B

Signos: A health-tech company personalizing weight loss journeys with simple, effective actions.

HQ
Burlingame, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
News
Website

Founded with a mission to revolutionize personal health management, Signos is a health-tech company focused on providing personalized weight loss journeys. By leveraging advanced wearable technology, Signos offers users actionable insights to improve their health and manage their metabolism effectively. The company’s core product is a wearable device that tracks blood sugar levels and provides tailored recommendations to optimize metabolic health. Signos targets individuals seeking a data-driven approach to weight loss and overall wellness.

Signos has garnered attention from notable figures in the health and tech industries, attracting significant investment to fuel its growth. The company has achieved key milestones, including the successful launch of its wearable device and the development of a user-friendly platform that integrates seamlessly with daily routines. Through its innovative approach, Signos has made a substantial impact on the health-tech market, empowering users to make informed decisions about their diet and lifestyle for better long-term health outcomes.

Signos - Similar Companies

Healbe logo

Healbe

healbe.com

Aura Devices logo

Aura Devices

auradevices.io

NutriSense logo

NutriSense

nutrisense.io

Whoop logo

Whoop

whoop.com

Heads Up Health logo

Heads Up Health

headsuphealth.com

MetaLogics logo

MetaLogics

Well logo

Well

well.co

January logo

January

january.ai

Pnoē logo

Pnoē

pnoe.com

Welltory logo

Welltory

welltory.com

BodBot logo

BodBot

bodbot.com

Intellihealth logo

Intellihealth

intellihealth.co

Innsightful logo

Innsightful

Glimpse Wearables logo

Glimpse Wearables

Signos - Quick Facts

Who are Signos' competitors?

Companies similar to Signos include Healbe, Aura Devices, NutriSense and Whoop.

When was Signos founded?

Signos was founded in 2018.

Where is Signos' headquarters located?

Signos' headquarters is located in Burlingame, CA, US.

When was Signos' last funding round?

Signos' most recent funding round was for $20M (USD) in October 2023.

How much has Signos raised to-date?

As of Oct 21, 2023, Signos has raised a total of $37M (USD).

How many employees does Signos have?

Signos has 30 employees as of Feb 4, 2024.

Signos - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Health Tech
Tags
  • Healthtech
  • Wearable
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software